In these studies, the subpopulation of CD44+/CD24−/low cells, enriched for CSCs, of two breast cancer cell lines and the primary culture of patient breast cancer cells, demonstrated enhanced expression of phosphorylated ATM after radiation, which correlates with increased radioresistance. This evidence concerns the gene CD44 and breast cancer.